1. AAV-shRNA vectors as an alternative therapy for human basal-like breast cancer. (July 2016) Authors: Pinto, C.; Ribeiro, A.S.; Silva, G.; Oliveira, M.; Coroadinha, A.S.; Peixoto, C.; Barbas, A.; Brito, C.; Paredes, J.; Alves, P.M. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition. Issue 5 (5th June 2018) Authors: Goncalves, J.; Santos, M.; Acurcio, R.; Iria, I.; Gouveia, L.; Matos Brito, P.; Catarina Cunha‐Santos, A.; Barbas, A.; Galvão, J.; Barbosa, I.; Aires da Silva, F.; Alcobia, A.; Cavaco, M.; Cardoso, M.; Delgado Alves, J.; Carey, J. J.; Dörner, T.; Eurico Fonseca, J.; Palmela, C.; Torres, J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 5(2018) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Short-term outcomes after implementation of ERAS in liver surgery. (September 2018) Authors: Landa, K.; Shah, K.; Thacker, J.; Lane, W.; Knechtle, S.; Ravindra, K.; Barbas, A.; Zani, S. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗